Track the Generate Biomedicines, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 3 September 2026 (Cession). Among the most active insiders: ARNOLD FRANCES. The full history is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€237,972
4 ops.
Buy Volume
€13,778
1 ops.
Sell Volume
52Σ signal
Buys €237,972€13,778 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Generate Biomedicines, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias basadas en proteínas. Utiliza una plataforma de diseño de proteínas para crear terapias innovadoras.